Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiyuan Yingze Kaiyuan Pharmaceutical Research Institute was a specialized research entity located in Taiyuan, Shanxi Province, China. Founded in 1992, the institute focused on the research and development of innovative treatments for chronic skin diseases, particularly psoriasis. It was established by Zhang Kaiyuan, a prominent figure in Chinese dermatological research, and served as the scientific precursor to the commercial entity Shanxi Kaiyuan Pharmaceutical. The institute's work combined traditional Chinese medicinal principles with modern pharmaceutical research to produce the Kaiyuan series of dermatological products. Although the institute is now formally deregistered, its research contributions continue to influence the product portfolio of its successor companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiyuan Yingze Kaiyuan Pharmaceutical Research Institute.